Immunology and Cell Biology · 2016 · 25 citations · 19 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyImmunotherapyCancer ImmunotherapyCell-based ImmunotherapyCell-mediated ImmunityEffector T Cell FunctionT Cell BiologyTumor-infiltrating LymphocytesCell Differentiation PotentialCytotoxic Effector FunctionCytotoxic T Lymphocyte FunctionDifferentiationDifferentiation PotentialEx Vivo Cell ExpansionT Cell-based ImmunotherapyT-cell Therapy
Immunotherapies based on the autologous adoptive transfer of ex vivo-manipulated T cells are rapidly evolving for the treatment of both metastatic and primary malignancies. However, extended ex vivo culturing reduces the functionality of isolated T cells. Cryopreservation of rapidly expanded T cells for subsequent use throughout an immunotherapeutic regimen is a highly desirable recourse, thus far encumbered by a lack of studies investigating its effects on effector T-cell functionality. Here we directly compare murine tumour-reactive CD8(+) T cells cryopreserved during ex vivo expansion to freshly isolated populations. We show that cryopreservation fully conserves the differentiation potential of effector T cells, secretion of pro-inflammatory cytokines, cytotoxic function and does not impair the three-dimensional scanning motility of T cells or their capacity to infiltrate and reject tumours.
19
Christopher A. Klebanoff, Luca Gattinoni, Parizad Torabi‐Parizi et al. · Proceedings of the National Academy of Sciences · 2005 · 972 citations · Full text
Life Sciences, Immunology, Oncology +17
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
Jennifer Landsberg, Judith Kohlmeyer, Marcel Renn et al. · Nature · 2012 · 641 citations
Medicine, Immunology, Oncology +14